missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Gibco™ Mouse CCL22 (MDC) Recombinant Protein
Description
Reconstitution: We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute MDC in sterile, distilled water to a concentration of 0.1-1.0 mg/mL. Further dilutions should be made in aqueous buffers supplemented with carrier protein, such as 0.1-1.0% BSA. Storage: This lyophilized preparation is stable at 2°C to 8°C, but should be stored at -20°C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2°C to 8°C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20°C. Avoid repeated freeze/thaw cycles.
CCL22 may play a role in the trafficking of activated/effector T-lymphocytes to inflammatory sites and other aspects of activated T-lymphocyte physiology. Also, it is a chemotactic for monocytes. dendritic cells and natural killer cells. CCL22 is a mild chemoattractant for primary activated T-lymphocytes and a potent chemoattractant for chronically activated T-lymphocytes but has no chemattractant activity for neutrophils, eosinophils, and resting T-lymphocytes. Binds to CCR4.
Specifications
Specifications
| Accession Number | O88430 |
| For Use With (Application) | Bioactivity |
| Formulation | Protein with no preservative |
| Gene ID (Entrez) | 20299 |
| Molecular Weight (g/mol) | 7.8 kDa |
| Name | Mouse CCL22 (MDC) |
| Purification Method | Purified |
| Quantity | 20 μg |
| Storage Requirements | -20°C |
| Regulatory Status | RUO |
| Show More |